Loading...
Docoh

Regen BioPharma (RGBP)

Regen Biopharma, Inc. engages in the development of regenerative medical applications licensed from other companies. It focuses on the immunology and immonutherapy research for the areas of Hematopoiesis, Breast Cancer, Liver Cancer, Leukemia, Myelodysplastic Syndrome, and Aplastic Anemia. The company was founded on April 24, 2012 and is headquartered in La Mesa, CA.

Company profile

RGBP stock data

Calendar

22 Jul 22
30 Sep 22
30 Sep 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Sep 21 Sep 20 Sep 19 Sep 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 110.99K 110.99K 110.99K 110.99K 110.99K 110.99K
Cash burn (monthly) 41.23K 6.43K 19.64K 30.72K 41.23K 132.39K
Cash used (since last report) 125.16K 19.53K 59.61K 93.27K 125.16K 401.91K
Cash remaining -14.17K 91.47K 51.38K 17.73K -14.17K -290.92K
Runway (months of cash) -0.3 14.2 2.6 0.6 -0.3 -2.2

Beta Read what these cash burn values mean

13F holders Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Largest transactions Shares Bought/sold Change

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: Consulting, cumulative, ISSUD, restatement
Removed: advertisement, placement
Proxies
No filings